![](/img/cover-not-exists.png)
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase
Tran, Arthur-Quan, Erim, Daniel O., Sullivan, Stephanie A., Cole, Ashley L., Barber, Emma L., Kim, Kenneth H., Gehrig, Paola A., Wheeler, Stephanie B.Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.12.015
Date:
December, 2017
File:
PDF, 269 KB
english, 2017